Envestnet Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.79M | Buy |
|
|||||
|
2025
Q1 | $3.11M | Sell |
|
|||||
|
2024
Q4 | $2.97M | Sell |
|
|||||
|
2024
Q3 | $3.72M | Sell |
|
|||||
|
2024
Q2 | $8.1M | Sell |
|
|||||
|
2024
Q1 | $12.1M | Sell |
|
|||||
|
2023
Q4 | $15.1M | Buy |
|
|||||
|
2023
Q3 | $11.1M | Buy |
|
|||||
|
2023
Q2 | $5.78M | Buy |
|
|||||
|
2023
Q1 | $5.68M | Buy |
|
|||||
|
2022
Q4 | $5.77M | Buy |
|
|||||
|
2022
Q3 | $4.71M | Buy |
|
|||||
|
2022
Q2 | $4.47M | Sell |
|
|||||
|
2022
Q1 | $4.89M | Sell |
|
|||||
|
2021
Q4 | $13.7M | Buy |
|
|||||
|
2021
Q3 | $11.7M | Sell |
|
|||||
|
2021
Q2 | $13M | Sell |
|
|||||
|
2021
Q1 | $12M | Buy |
|
|||||
|
2020
Q4 | $13.1M | Buy |
|
|||||
|
2020
Q3 | $11.3M | Buy |
|
|||||
|
2020
Q2 | $17.6M | Buy |
|
|||||
|
2020
Q1 | $11.4M | Buy |
|
|||||
|
2019
Q4 | $10.1M | Buy |
|
|||||
|
2019
Q3 | $7.47M | Sell |
|
|||||
|
2019
Q2 | $17M | Buy |
|
|||||
|
2019
Q1 | $14.8M | Buy |
|
|||||
|
2018
Q4 | $11.9M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $346K | Buy |
|
|||||
|
2018
Q1 | $269K | Buy |
|
|||||
|
2017
Q4 | $157K | Buy |
|
|||||
|
2017
Q3 | $120K | Sell |
|
|||||
|
2017
Q2 | $226K | Sell |
|
|||||
|
2017
Q1 | $227K | Sell |
|
|||||
|
2016
Q4 | $235K | Buy |
|
|||||
|
2016
Q3 | $262K | Sell |
|
|||||
|
2016
Q2 | $1.18M | Buy |
|
|||||
|
2016
Q1 | $1.13M | Buy |
|
|||||
|
2015
Q4 | $1.27M | Buy |
|
|||||
|
2015
Q3 | $1.2M | Buy |
|
|||||
|
2015
Q2 | $1.49M | Sell |
|
|||||
|
2015
Q1 | $1.7M | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $5K | Sell |
|
|||||
|
2014
Q1 | $8K | Buy |
|
|||||
|
2013
Q4 | $4K | Sell |
|
|||||
|
2013
Q3 | $25K | Buy |
|